(Q1)Aug 31, 2024 | (FY)May 31, 2024 | (Q4)May 31, 2024 | (Q3)Feb 29, 2024 | (Q2)Nov 30, 2023 | (Q1)Aug 31, 2023 | (FY)May 31, 2023 | (Q4)May 31, 2023 | (Q3)Feb 28, 2023 | (Q2)Nov 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -33.51%-541.75K | -177.70%-1.22M | -55.81%-45.5K | 73.68%267.47K | -61.51%-1.03M | -632.41%-405.77K | 50.64%-437.61K | 90.10%-29.2K | 421.00%154K | -67.15%-638.61K |
Net income from continuing operations | 15.80%-598.48K | -44.37%-2.02M | -47.06%-646.13K | -165.39%-93.8K | -94.33%-571.72K | 12.34%-710.76K | 2.90%-1.4M | -18.74%-439.36K | 125.31%143.46K | -103.52%-294.2K |
Operating gains losses | 212.97%21.36K | -1.33%81.14K | 518.74%165.13K | -300.70%-56.41K | 97.53%-8.67K | -104.25%-18.91K | 378.51%82.23K | -213.83%-39.43K | -79.32%28.11K | -54.38%-351.35K |
Depreciation and amortization | 84.84%150.3K | 229.71%423.4K | 334.41%193.3K | 145.73%74.7K | 137.01%74.08K | 265.29%81.31K | 14.29%128.42K | 78.02%44.5K | -6.60%30.4K | 11.28%31.26K |
Asset impairment expenditure | -26.99%184.01K | 80.35%570.57K | -27.41%106.08K | 61.81%-133.55K | -33.45%346K | --252.04K | --316.36K | --146.13K | ---349.69K | --519.92K |
Unrealized gains and losses of investment securities | -232.35%-50.55K | 755.28%42.89K | 57.18%30.86K | -86.68%-48.87K | --22.7K | --38.19K | ---6.55K | --19.63K | ---26.18K | --0 |
Remuneration paid in stock | 514.99%96.49K | 1.67%188.41K | 240.41%110.8K | 10.11%49.29K | -79.51%12.63K | -66.14%15.69K | -60.79%185.31K | -78.12%32.55K | -69.45%44.76K | -32.75%61.67K |
Other non cashItems | ---- | -3,345.48%-168.05K | --0 | -64.47%464 | -13,339.83%-169.87K | 7.22%1.35K | 258,800.00%5.18K | 134.51%1.33K | 0.00%1.31K | 0.00%1.28K |
Change In working capital | -433.13%-344.88K | -231.26%-331.19K | -102.70%-5.55K | 68.77%475.65K | -21.31%-736.6K | -117.38%-64.69K | 34,701.24%252.31K | 258.49%205.44K | 39.15%281.83K | -363.56%-607.19K |
-Change in receivables | -140.83%-196.45K | -87.70%-995.86K | -155.90%-644.56K | -145.78%-163.82K | 81.68%-105.91K | -39.35%-81.57K | ---530.56K | ---251.89K | 104.66%357.84K | -457.63%-577.99K |
-Change in inventory | 285.11%87 | -104.33%-2.69K | 11.79%-6.47K | -115.32%-114 | -91.17%3.93K | -100.19%-47 | --62.2K | ---7.33K | --744 | --44.58K |
-Change in prepaid assets | 158.17%28.68K | -1,194.84%-275.18K | 1,115.71%24.45K | -755.28%-56.15K | -2,183.77%-194.17K | -342.07%-49.31K | --25.13K | --2.01K | -109.53%-6.57K | 126.09%9.32K |
-Change in payables and accrued expense | -1,286.21%-323.96K | -31.55%175.12K | 79.77%378.23K | 570.53%72.95K | -1,859.44%-252.69K | -131.66%-23.37K | --255.82K | --210.39K | 84.68%-15.5K | -253.96%-12.9K |
-Change in other working capital | 63.78%146.76K | 74.53%767.43K | -3.75%242.81K | 1,238.75%622.79K | -167.45%-187.77K | -71.31%89.61K | --439.72K | --252.26K | ---54.69K | ---70.21K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -33.51%-541.75K | -177.70%-1.22M | -55.81%-45.5K | 73.68%267.47K | -61.51%-1.03M | -632.41%-405.77K | 50.64%-437.61K | 90.10%-29.2K | 421.00%154K | -67.15%-638.61K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -12.40%-510.89K | 30.40%-593.91K | -477.42%-801.57K | 212.25%622.49K | 137.91%39.71K | -11.83%-454.54K | -1,708.81%-853.38K | 169.46%212.38K | -495.35%-554.57K | -653.22%-104.74K |
Net PPE purchase and sale | 4.80%-432.72K | -31.44%-1.57M | -69.25%-1.11M | 543.65%144.49K | -206.56%-157.29K | 1.16%-454.54K | -1,040.84%-1.2M | -3,216.90%-654.21K | 65.04%-32.57K | -268.98%-51.31K |
Net investment purchase and sale | ---- | 195.79%500K | --0 | 191.57%478K | ---- | ---- | ---522K | --0 | ---522K | ---- |
Net other investing changes | ---78.17K | -44.53%480.67K | --305.67K | --0 | ---- | ---- | 1,398.55%866.58K | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -12.40%-510.89K | 30.40%-593.91K | -477.42%-801.57K | 212.25%622.49K | 137.91%39.71K | -11.83%-454.54K | -1,708.81%-853.38K | 169.46%212.38K | -495.35%-554.57K | -653.22%-104.74K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -4,687.50%-4.21K | 1,082.10%61.36K | -116.39%-2.24K | 12.23%-14.69K | 512.03%78.38K | 98.06%-88 | -99.80%5.19K | -99.28%13.66K | -103.50%-16.73K | -20.91%12.81K |
Net issuance payments of debt | -4,687.50%-4.21K | -129.14%-102.01K | -146.43%-2.24K | -391.89%-82.31K | -5.64%-17.37K | 99.46%-88 | 30.02%-44.52K | 130.36%4.82K | -7.23%-16.73K | 3.60%-16.45K |
Proceeds from stock option exercised by employees | ---- | 228.66%163.38K | -99.99%1 | --67.63K | ---- | ---- | -96.14%49.71K | -98.99%8.83K | --0 | -12.03%29.25K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -4,687.50%-4.21K | 1,082.10%61.36K | -116.39%-2.24K | 12.23%-14.69K | 512.03%78.38K | 98.06%-88 | -99.80%5.19K | -99.26%13.66K | -103.11%-16.73K | -20.91%12.81K |
Net cash flow | ||||||||||
Beginning cash position | -46.00%2.05M | -25.29%3.8M | -29.67%2.9M | -49.61%2.03M | -38.13%2.94M | -25.29%3.8M | 50.03%5.08M | 21.48%4.12M | 31.43%4.02M | 38.16%4.75M |
Current changes in cash | -22.83%-1.06M | -35.93%-1.75M | -161.19%-849.3K | 736.00%875.27K | -25.02%-913.35K | -157.01%-860.39K | -175.83%-1.29M | -119.24%-325.17K | -68.88%104.7K | -92.37%-730.55K |
End cash Position | -66.16%994.48K | -46.00%2.05M | -46.00%2.05M | -29.67%2.9M | -49.61%2.03M | -38.13%2.94M | -25.29%3.8M | -25.29%3.8M | 21.48%4.12M | 31.43%4.02M |
Free cash from | -13.27%-974.47K | -72.70%-2.94M | -102.67%-1.31M | 461.34%499.01K | -66.75%-1.28M | -124.23%-860.3K | -71.95%-1.71M | -135.42%-645.26K | 162.99%88.9K | -93.23%-765.1K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data